BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28430637)

  • 1. Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer.
    Shoda K; Ichikawa D; Fujita Y; Masuda K; Hiramoto H; Hamada J; Arita T; Konishi H; Kosuga T; Komatsu S; Shiozaki A; Okamoto K; Imoto I; Otsuji E
    Oncotarget; 2017 Apr; 8(17):28796-28804. PubMed ID: 28430637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer.
    Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM
    Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective observation: Clinical utility of plasma Epstein-Barr virus DNA load in EBV-associated gastric carcinoma patients.
    Qiu MZ; He CY; Lu SX; Guan WL; Wang F; Wang XJ; Jin Y; Wang FH; Li YH; Shao JY; Zhou ZW; Yun JP; Xu RH
    Int J Cancer; 2020 Jan; 146(1):272-280. PubMed ID: 31162842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of Epstein-Barr virus DNA in plasma and stomach biopsies of patients with gastric cancer.
    Sarshari B; Ravanshad M; Rabbani A; Zareh-Khoshchehreh R; Mokhtari F; Khanabadi B; Mohebbi SR; Asadzadeh Aghdaei H
    Virus Genes; 2023 Jun; 59(3):351-358. PubMed ID: 36757510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
    Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
    Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach.
    Fukayama M; Hayashi Y; Iwasaki Y; Chong J; Ooba T; Takizawa T; Koike M; Mizutani S; Miyaki M; Hirai K
    Lab Invest; 1994 Jul; 71(1):73-81. PubMed ID: 8041121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
    Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK
    PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China.
    Liu S; Zhao Z; Han L; Liu S; Luo B
    PLoS One; 2016; 11(2):e0148342. PubMed ID: 26859565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
    Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
    Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2.
    Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F
    J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy.
    Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Shin J; Park YS; Moon MS; Kang YK
    Gastric Cancer; 2024 Jan; 27(1):146-154. PubMed ID: 38006567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
    Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
    World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
    Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in Epstein-Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis.
    Huang SC; Ng KF; Chen KH; Hsu JT; Liu KH; Yeh TS; Chen TC
    Oncol Rep; 2014 Aug; 32(2):530-8. PubMed ID: 24899228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
    Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
    J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).
    Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y
    Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
    Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK
    Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
    Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.